Older Adults Exercising On Time
ON TIME
1 other identifier
interventional
36
1 country
1
Brief Summary
There are indications from epidemiological cohort studies and animal experiments that timing of physical activity (also referred as "chronoactivity"), irrespective of intensity, impacts health and disease. In view of the detrimental effects of circadian misalignment, the large group of older people suffering from sleep problems, and the seeming importance of chronoactivity, the investigators will perform a randomised cross-over study that aims to uncover the effect of timing of physical activity on insomnia severity and related(circadian) health parameters in older adults with self-reported sleep problems. Here, the investigators hypothesize that timing of physical activity has a beneficial impact on insomnia symptoms and on circadian rhythms of additional health parameters (e.g., metabolic, psychosocial) in older people. To study this research hypothesis, the investigators will examine the effect of physical activity timing on insomnia severity in older adults with self-reported sleep problems. In addition, the investigators will examine the effect of physical activity timing on exploratory rhythmic parameters of biological clock function, physiology and metabolism, mental health, behavioural factors, and immune and cell signalling functions. For this study, a two-armed randomised cross-over study, Dutch speaking older adults between 60 and 80 years old (male and female) and having sleep problems (insomnia severity index\>10 points) from the general population in the Netherlands will be selected as participants for this study. Participants will perform one sedentary period and two period of increased physical activity with different daily patterns: 1)active morning; 2) active evening with a duration of 14 days each. In both active intervention arms, participants will follow an exercise program containing outdoor physical exercise sessions (Vitality Club) containing endurance and strength exercises, relative rest days of 30 minutes light intensity physical activity, and one Active@Home program; a 1-hour training session of various moderate to vigorous activities. The training sessions will be held either in the morning or evening (depending on the intervention arm) and will be one hour long. Study outcomes will be compared between the different intervention groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2024
CompletedStudy Start
First participant enrolled
May 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2024
CompletedFirst Posted
Study publicly available on registry
September 26, 2024
CompletedSeptember 26, 2024
September 1, 2024
2 months
March 12, 2024
September 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insomnia severity
Score on Insomnia Severity Index (ISI). Participants will be asked to fill out the ISI questionnaire (Dutch version) The ISI questionnaire consists of 7 questions and outcomes include: 'No clinically significant insomnia (0-7 points)', 'Subthreshold insomnia (8-14 points)', 'Moderate severity clinical insomnia (15-21 point), and 'Severe clinical insomnia (22-28 points)'.
4 times in total: at baseline T-3 (T= week), at T2 , T5, and at T8 (endline).
Secondary Outcomes (16)
Dim light melatonin onset (DLMO)
3 times in total: two weeks, five weeks and eight weeks after baseline.
Ecological monitoring assessment
3 periods in total of one week each: the second week, the fifth week and the eighth week.
Sleep quality - sleep duration
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
Sleep quality - sleep latency
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
Sleep quality - sleep stages
3 periods in total of 2 weeks each: weeks 1-2 , weeks 4-5, and weeks 7-8.
- +11 more secondary outcomes
Study Arms (2)
Group 1
OTHEROrder of interventions: Sedentary - Active morning - Active Evening
Group 2
OTHEROrder of the interventions: Sedentary - Active Evening - Active Morning
Interventions
The investigators will compare our interventions to a 14-day period of sedentary behavior, during which the participant will refrain from any moderate to vigorous exercise. Next, participants will participate in two interventions consisting each of a 14-day physical activity regimen. The active morning and active evening interventions are equal in content. Both groups will be instructed to refrain from any moderate to vigorous exercise for the rest of the day. Per intervention, a total of eight Vitality Club training session comprising of a combination of aerobic endurance training and resistance exercise training will be given by a trained sports coach or physical therapist specialized in geriatric physical therapy. During the weekends, participants will be asked to perform a 'relative rest' session with some light activity during the training time window of the intervention arm.
Eligibility Criteria
You may qualify if:
- Aged between 60 and 80 years old
- Retired
- Long lasting sleep problems (as assessed by a the screening questionnaire administered telephonically and by the ISI which will be filled out during the screening visit)
- Access to and ability to use a smart phone (Android or Apple)
You may not qualify if:
- Currently employed or working
- Extreme sleep chronotypes (measured by the Munich chronotype questionnaire)
- Participation in any sort of fasting regimen (e.g. intermitted fasting or Ramadan)
- Experienced recent (\<6 months) adverse life events (e.g., death of partner)
- Abnormal values in glucose metabolism, thyroid, liver or kidney function, or inflammation markers that after examination of the study doctor need immediate attention of a general practitioner or specialist.
- Diagnosed clinical depression
- Diagnosed neurodegenerative diseases (e.g. dementia or Parkinson's disease)
- Diagnosed sleep apnoea
- Diagnosed restless legs syndrome
- Use of beta-adrenergic blocking agents
- Use of sleep medication\*
- Injuries or other severe physical conditions (such as active arthrosis) that inhibits physical activity
- Travelled across time zones one week prior to start of study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leiden University Medical Centerlead
- Netherlands Organisation of Scientific Research (NWO)collaborator
- Centre for Human Drug Research, Netherlandscollaborator
- Chrono@Workcollaborator
- Corsano Health B.V.collaborator
- M-Path Leuvencollaborator
Study Sites (1)
Leiden University Medical Center
Leiden, South Holland, 2333ZA, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diana van Heemst, PhD
Leiden University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 12, 2024
First Posted
September 26, 2024
Study Start
May 2, 2024
Primary Completion
June 27, 2024
Study Completion
June 27, 2024
Last Updated
September 26, 2024
Record last verified: 2024-09